GlobalData on MSN
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback